Need to change the name of proprietary Chinese medicine pharmaceutical packaging machinery companies can live?
Recently, the State Food and Drug Administration issued the "Guidelines for the Common Name Naming Technology of Chinese Patent Medicine" (hereinafter referred to as "the Principles") and the "Notice on Regulating the Naming of the Common Names of Chinese Medicines Listed on the List" (hereinafter referred to as "Notice" "). The "Principles" and "Notice" require that the naming of proprietary Chinese medicines should not use exaggerated, self-proclaimed and unrealistic terms such as "strong, quick-acting, imperial, and secret." However, the proprietary Chinese name from the ancient classics, whose generic name is named after the classic name prescription, is not included in the scope of the specification.
Some experts said that Chinese medicines like to "work hard" on the name is mainly due to the lack of clear evidence-based research on the composition, mechanism of action and efficacy of proprietary Chinese medicines. The release of the new naming regulations will have a large number of Chinese patent medicine companies facing the status quo, but it will also promote the industry to change the development of ideas, and more effectively protect the lives of patients.
Chinese patent medicines are medicines and should implement national laws and regulations on medicines. The author understands that pharmaceutical packaging, labels, and instructions must be printed in accordance with the provisions of Article 54 of the Drug Administration Law and the regulations of the drug regulatory authority under the State Council. The naming of Chinese patent medicine companies can no longer be "willful". Changing names and changing packaging will become the top priority for most Chinese patent medicine companies. Affected by this, pharmaceutical packaging machinery will usher in a new round of market demand.
Pharmaceutical packaging machinery provides the necessary guarantee for the modern processing and mass production of pharmaceuticals. As an external form of pharmaceuticals, pharmaceutical packaging is strict from materials to methods, from environmental requirements to labeling, and has strict restrictions. It also makes pharmaceutical packaging machinery a relatively independent industry.
Although compared with foreign pharmaceutical packaging machinery, there is still a certain distance in China, but from scratch, from small to large, from imitation to independent research and development, the domestic pharmaceutical packaging machinery industry has a certain scale, and during the GMP certification period. Gained a lot of room for development. The change of the name of this Chinese patent medicine will inevitably drive the demand for pharmaceutical packaging machinery, and the industry may usher in a new round of growth.
For the growth brought about by the rebranding of Chinese patent medicines, industry insiders said that there will be some improvement in market demand, but the key is still to provide high-quality, high-performance, high-tech equipment with manufacturers of pharmaceutical packaging machinery. The author understands that in terms of product structure, although the types of equipment are constantly enriched, there is still a lack of high-precision and large-scale products. In terms of product quality, some experts have said that most pharmaceutical companies pay more attention to the quality of equipment, but In the case of similar quality, the factors such as equipment performance, service life and control level have become the focus of customers' consideration, and domestic enterprises still need to work hard.
In addition, in terms of product innovation, there are still some companies still staying in the imitation stage. In an era of increasing emphasis on product innovation, only being satisfied with imitation does not bring long-term benefits. In the face of market demand brought about by the rebranding of proprietary Chinese medicines, related companies may not be able to obtain this benefit. In addition, in terms of enterprises, according to the analysis of relevant people, the pharmaceutical packaging machinery industry is mainly dominated by small and medium-sized enterprises, and the industry leader team is relatively weak.
Although China's pharmaceutical packaging machinery industry still has a long way to go, but in the face of market demand, as well as industry trends, there are still many companies actively learning advanced production technology, research and development and production of modern equipment products in line with industry trends. For example, Tianjin Binhai Licheng Packaging Machinery Manufacturing Co., Ltd., Guangzhou Santuo Identification Technology Co., Ltd., Jinan Languang Electromechanical Technology Co., Ltd., Jinan Saicheng Electronic Technology Co., Ltd., etc. are all committed to innovative product technology, promoting pharmaceutical packaging machinery to automation, electromechanical The development of integration and intelligence.
From the equipment exhibited at the recently concluded SWop 2017 Packaging World (Shanghai) Expo, the intelligent manufacturing of packaging equipment is the trend of the times, and many exhibitors' exhibits reflect this trend. For example, intelligent software and machine links can realize intelligent and personalized requirements, which has greatly helped pharmaceutical companies to reduce costs and improve manufacturing processes.
Chinese patent medicines are only one kind of medicines, but their strict requirements on packaging and the increase in market demand are all released in the signal of drug delivery enterprises: pharmaceutical packaging equipment with high quality, advanced technology and current trend will be Chinese medicine companies. Ideal products, to meet these needs, the relevant companies have to invest more energy. However, on the other hand, the rebranding of Chinese patent medicines will not only bring about a high demand for equipment, but also promote the standardization, rationalization and intelligent development of the entire pharmaceutical packaging machinery industry.
Both IgM and IgG are immunoglobulin which are produced by the immune system to provide protectionagainst the 2019-nCoV. Some patients with negative results in nucleic acid test show positive in IgM test,indicating that the IgG / IgM detection is one of the effective methods for the diagnosis of 2019-nCoV.
Office Testing Kit
NINGBO AUTRENDS INTERNATIONAL TRADE CO., LTD , https://www.metests.com